A University of Nottingham research team specializing in childhood eczema has been shortlisted for an award from the BMJ Group. They are amongst five leading research groups that have been shortlisted in the category for Outstanding Achievement in Evidence Based Health Care.
The Centre of Evidence-Based Dermatology (CEBD), which is based at The University of Nottingham, has an international reputation for skin research and evidence-based practice. It has been shortlisted for its pivotal role in bringing evidence from research into the treatment of skin diseases; and for the resulting policy changes that this has informed.
Professor Williams said: “We will be up against some fantastic research teams in the field of evidence based practice, and just being shortlisted for the final is a great honour for our team.”
The inaugural BMJ Group Awards, which take place on April 2 2009, will recognise individuals, organisations and initiatives that can demonstrate outstanding and measurable contributions to health care. They include awards for corporate social responsibility, clinical research, healthcare communication, medical education, quality improvement, global leadership and lifetime achievement.
Around 2000 people have already taken part in trials carried out by the CEBD. The team, led by Hywel Williams, Professor of Dermato-Epidemiology, has published many papers with the BMJ, which have played a significant role in changing medical practice.
Skin disease affects peoples’ self esteem and confidence, especially as society’s expectations for an unblemished skin are so high. However, at any one time about a quarter to a third of the population have a skin disease that can benefit from medical care. It is one of the commonest reasons why people go to their GP.
Although the Centre of Evidence-Based Dermatology specialises in childhood eczema it is also currently running clinical trials on basal cell carcinoma of the skin (the commonest form of cancer in humans), bullous pemphigoid (a rare blistering condition of the skin), pyoderma gangrenosum (a rare mutilating and painful condition of the skin) and cellulitis (a bacterial infection that typically involves the lower leg).
— Ends —
Notes to editors
: The University of Nottingham is ranked in the UK's Top 10 and the World's Top 100 universities by the Shanghai Jiao Tong (SJTU) and Times Higher (THE) World University Rankings.
More than 90 per cent of research at The University of Nottingham is of international quality, according to RAE 2008, with almost 60 per cent of all research defined as ‘world-leading’ or ‘internationally excellent’. Research Fortnight analysis of RAE 2008 ranks the University 7th in the UK by research power. In 27 subject areas, the University features in the UK Top Ten, with 14 of those in the Top Five.
The University provides innovative and top quality teaching, undertakes world-changing research, and attracts talented staff and students from 150 nations. Described by The Times as Britain's "only truly global university", it has invested continuously in award-winning campuses in the United Kingdom, China and Malaysia. Twice since 2003 its research and teaching academics have won Nobel Prizes. The University has won the Queen's Award for Enterprise in both 2006 (International Trade) and 2007 (Innovation — School of Pharmacy), and was named ‘Entrepreneurial University of the Year’ at the Times Higher Education Awards 2008.
Nottingham was designated as a Science City in 2005 in recognition of its rich scientific heritage, industrial base and role as a leading research centre. Nottingham has since embarked on a wide range of business, property, knowledge transfer and educational initiatives (www.science-city.co.uk) in order to build on its growing reputation as an international centre of scientific excellence. The University of Nottingham is a partner in Nottingham: the Science City.